IGFBP6 and metabolic dysfunction-associated steatotic liver disease: IGFBP6 is highly expressed in hepatic stellate cells and is strongly correlated with hepatic fibrosis, steatosis severity, and a non-alcoholic fatty liver disease (NAFLD) activity score 16.